Exclusive Video Marketing Software for Startups 

HotSpot Therapeutics Secures $65M

HotSpot Therapeutics Secures $65M Back to HomeBOSTON, MA, HotSpot Therapeutics has announced the completion of a $65 million Series B financing. HotSpot Therapeutics, a biotechnology company pioneering the discovery and development of first-in-class allosteric therapies targeting nature's regulatory sites, today announced the completion of a $65 million Series B financing. "We are thrilled to have the support of a top tier investor syndicate to realize our vision of designing and developing first-in-class allosteric medicines," said Jonathan Montagu, CEO and co-founder of HotSpot Therapeutics. HotSpot Therapeutics is creating a new paradigm for allosteric medicines that exploits natural control mechanisms. About HotSpot TherapeuticsHotSpot Therapeutics is targeting nature's regulatory mechanisms to create allosteric medicines that exhibit high precision and potency.

Startup Around is now on Telegram and Whatsapp. For the best startup stories & resources, subscribe us on Telegram & Whatsapp.
World-class video marketing software for startups